单一截骨技术用于长骨恶性骨肿瘤冷冻自体骨(带蒂冷冻)能否实现骨愈合与局部肿瘤控制?
该回顾性研究纳入32例股骨、胫骨或肱骨原发肉瘤患者,采用单干骺端截骨的带蒂冷冻自体骨技术重建。作者认为该技术对化疗反应好、可行间室切除且保留至少2cm软骨下区的患者是合理替代方案,但需进一步研究与其他重建方式比较。
要点
- 局部复发率3.1%,非肿瘤并发症发生率25%,包括浅表皮肤烧伤、伤口感染、深静脉血栓和神经麻痹。
- 中位MSTS功能评分90%,5年平均无病生存时间58个月(95%CI 55-62个月)。
核心结论
- 该治疗对可进行间室切除的股骨、胫骨和肱骨肉瘤患者取得较好成功,且不涉及骨骺和上干骺端。
- 该技术避免了既往冷冻技术中的第二个截骨部位,除一例患者外均实现骨愈合。
- 并发症或局部复发较少,患者功能良好。
- 作者认为该技术不能用于所有长骨肉瘤,但对于对新辅助化疗反应好、可行间室切除且保留至少2cm软骨下区、骨量足以承受冷冻过程的患者是合理替代治疗。
- 作者认为在专科中心接受过回收技术培训的经验丰富的外科医生对实施该技术至关重要,需进一步研究比较该技术与其他重建方式。
研究设计与样本
- 回顾性研究,2014年至2017年治疗87例股骨、胫骨或肱骨原发肉瘤患者,其中49%(43例)符合条件,进一步排除9%(8例)骨质量不足者(CT评估皮质厚度小于50%),最终32例接受单干骺端截骨带蒂冷冻技术(使用液氮)。
- 32例中男性20例、女性12例,中位年龄18岁(范围13-48岁),中位随访55个月(范围48-63个月)。
- 评估骨愈合(定义为6个月内四层皮质中三层骨桥接)、局部复发比例、非肿瘤并发症发生率和MSTS评分。
- 证据等级:IV级,治疗性研究。
主要发现
- 3%(32例中1例)患者发生骨不连(9个月时未愈合)。
- 中位MSTS评分为90%,末次随访时无转移证据。
- 9%(32例中3例)患者死亡。
- 局部复发率为3.1%(32例中1例)。
- 60个月(5年)时平均限制性无病生存时间为58个月(95%CI 55-62个月)。
临床怎么用
- 作者认为该技术是对于对新辅助化疗反应好、可行间室切除且保留至少2cm软骨下区、骨量足以承受冷冻过程的患者的合理替代治疗。
- 作者认为在专科中心接受过回收技术培训的经验丰富的外科医生对实施该技术至关重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Biological reconstruction by replanting the resected tumor-bearing segment is preferred by some surgeons when caring for a patient with a bone sarcoma. Frozen autografts are advantageous because they are cost-effective, provide an excellent fit, permit the maintenance of osteoinductive and osteoconductive properties, and are not associated with transmission of viral disease. The pedicle frozen autograft technique, in which only one osteotomy is made for the freezing procedure, keeping the affected segment in continuity with the host bone and soft tissue instead of two osteotomies, maintains the affected segment with the host bone and soft tissue. This could restore blood flow more rapidly in a frozen autograft than in a free-frozen autograft with two osteotomies. QUESTIONS/PURPOSES: (1) In what proportion of patients was union achieved by 6 months using this technique of frozen autografting? (2) What complications were observed in a small series using this approach? (3) What was the function of these patients as determined by Musculoskeletal Tumor Society (MSTS) score? (4) What proportion of patients experienced local recurrence? METHODS: Between 2014 and 2017, we treated 87 patients for primary sarcomas of the femur, tibia, or humerus. Of those, we considered patients who could undergo intercalary resection and showed a good response to neoadjuvant chemotherapy as potentially eligible for this technique. Based on these criteria, 49% (43 patients) were eligible; a further 9% (eight) were excluded because of inadequate bone quality (defined as cortical thickness less than 50% by CT assessment). We retrospectively studied 32 patients who were treated with a single metaphyseal osteotomy, the so-called pedicle freezing technique, which uses liquid nitrogen. There were 20 men and 12 women. The median age was 18 years (range 13 to 48 years). The median follow-up duration was 55 months (range 48 to 63 months). Patients were assessed clinically and radiologically regarding union (defined in this study as bony bridging of three of four cortices by 6 months), the proportion of patients experiencing local recurrence, the occurrence of nononcologic complications, and MSTS scores. RESULTS: Three percent (one of 32) of the patients had nonunion (no union by 9 months). The median MSTS score was 90%, with no evidence of metastases at the final follow-up interval. Nine percent (three of 32) of our patients died. The local recurrence rate was 3.1% (one of 32 patients). The mean restricted disease-free survival time at 60 months (5 years) was 58 months (95% CI 55 to 62 months). Twenty-five percent of patients (eight of 32) experienced nononcologic complications. This included superficial skin burns (two patients), superficial wound infection (two patients), deep venous thrombosis (one patient), transient nerve palsy (two patients), and permanent nerve palsy (one patient). CONCLUSION: This treatment was reasonably successful in patients with sarcomas of the femur, tibia, and humerus who could undergo an intercalary resection, and this treatment did not involve the epiphysis and upper metaphysis. It avoids a second osteotomy site as in prior reports of freezing techniques, and union was achieved in all but one patient. There were few complications or local recurrences, and the patients' function was shown to be good. This technique cannot be used in all long-bone sarcomas, but we believe this is a reasonable alternative treatment for patients who show a good response to neoadjuvant chemotherapy, those in whom intercalary resection is feasible while retaining at least 2 cm of the subchondral area, and in those who have adequate bone stock to withstand the freezing process. Experienced surgeons who are well trained on the recycling technique in specialized centers are crucial to perform the technique. Further study is necessary to see how this technique compares with other reconstruction options. LEVEL OF EVIDENCE: Level IV, therapeutic study.
引用
- El Masry AM, Azmy SI, Rahman Mustafa MA, et al. Does A Single Osteotomy Technique for Frozen Autograft (Pedicled Freezing) in Patients With Malignant Bone Tumors of the Long Bones Achieve Union and Local Tumor Control? Clin Orthop Relat Res. 2023. PMID: 37589950. doi:10.1097/CORR.0000000000002788
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。